The Case | Hypereosinophilia in a hemodialysis patient
Kidney Int
.
2022 Mar;101(3):657-658.
doi: 10.1016/j.kint.2021.10.003.
Authors
Gaspard Lamy
1
,
Jean-Emmanuel Kahn
2
,
Tessa Huscenot
2
,
Mathilde Dargelos
1
,
Eve Vilaine
1
,
Aymeric Couturier
1
,
Panha Chhom
1
,
Hamza Ayari
3
,
Ziad Albert Massy
4
,
Marie Essig
5
Affiliations
1
Nephrology and Dialysis Department, Ambroise Paré Hospital, Boulogne-Billancourt, France.
2
Internal Medicine Department, Ambroise Paré Hospital, Boulogne-Billancourt, France.
3
Nephrology and Dialysis Department, Edouard Rist Hospital, Paris, France.
4
Nephrology and Dialysis Department, Ambroise Paré Hospital, Boulogne-Billancourt, France; Paris-Saclay University, UVSQ, INSERM U1018, Villejuif, France.
5
Nephrology and Dialysis Department, Ambroise Paré Hospital, Boulogne-Billancourt, France; Paris-Saclay University, UVSQ, INSERM U1018, Villejuif, France. Electronic address: marie.essig@aphp.fr.
PMID:
35190048
DOI:
10.1016/j.kint.2021.10.003
No abstract available
MeSH terms
Eosinophilia* / diagnosis
Eosinophilia* / etiology
Humans
Renal Dialysis / adverse effects